Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system

BACKGROUND: Current investigations suggest that the Base Excision Repair (BER) system may change DNA repair capacity and affect clinical gastric cancer progression such as overall survival. However, the prognostic value of BER system members in gastric cancer remains unclear. METHODS: We explored th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Fubiao, Tang, Hengjie, Wang, Cheng, Wang, Zixiang, Yu, Fangyi, Chen, Bicheng, Sun, Linxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750847/
https://www.ncbi.nlm.nih.gov/pubmed/31571995
http://dx.doi.org/10.2147/CMAR.S217375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750847/
https://www.ncbi.nlm.nih.gov/pubmed/31571995
http://dx.doi.org/10.2147/CMAR.S217375

Ejemplares similares